Table 2.
Variable/Group | Evaluation schedule | p-group | p-moment | p-interaction | |||
2-days | 2-weeks | 4-weeks | 6-weeks | ||||
BMS | < 0.001 | < 0.001 | < 0.001 | ||||
Control | |||||||
Mean ± DP | 0 ± 0 | 1.1 ± 0.6 | 2 ± 0 | 2.8 ± 0.5 | |||
Median (min–max) | 0 (0–0) | 1 (0–2) | 2 (2–2) | 3 (2–3) | |||
GM1 | |||||||
Mean ± DP | 0.1 ± 0.4 | 1.8 ± 0.5 | 3.1 ± 0.4 | 4.6 ± 0.5 | |||
Median (min–max) | 0 (0–1) | 2 (1–2) | 3 (3–4) | 5 (4–5) | |||
Erythropoietin | |||||||
Mean ± DP | 0 ± 0 | 1.8 ± 0.7 | 2.4 ± 0.5 | 3.3 ± 0.7 | |||
Median (min–max) | 0 (0–0) | 2 (1–3) | 2 (2–3) | 3 (2–4) | |||
GM1+Erythropoietin | |||||||
Mean ± DP | 0 ± 0 | 1.5 ± 0.9 | 3.4 ± 0.5 | 3.9 ± 0.6 | |||
Median (min–max) | 0 (0–0) | 1,5 (0–3) | 3 (3–4) | 4 (3–5) | |||
MFS | < 0.001 | < 0.001 | < 0.001 | ||||
Control | |||||||
Mean ± DP | 0 ± 0 | 0.9 ± 0.4 | 2 ± 0.8 | 2.6 ± 0.5 | |||
Median (min–max) | 0 (0–0) | 1 (0–1) | 2 (1–3) | 3 (2–3) | |||
GM1 | |||||||
Mean ± DP | 0.1 ± 0.4 | 1.8 ± 0.5 | 4 ± 0.5 | 6.8 ± 0.7 | |||
Median (min–max) | 0 (0–1) | 2 (1–2) | 4 (3–5) | 7 (5–7) | |||
Erythropoietin | |||||||
Mean ± DP | 0 ± 0 | 1.9 ± 0.6 | 2.4 ± 0.7 | 4.3 ± 0.5 | |||
Median (min–max) | 0 (0–0) | 2 (1–3) | 2 (2–4) | 4 (4–5) | |||
GM1+Erythropoietin | |||||||
Mean ± DP | 0 ± 0 | 1.8 ± 1 | 4.4 ± 0.7 | 5.4 ± 0.7 | |||
Median (min–max) | 0 (0–0) | 2 (0–3) | 4.5 (3–5) | 5.5 (4–6) |
EEG with normal distribution and identity binding function with AR (1) correlation matrix between moments.